Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Local Advanced Non-small Cell Lung Cancer”

49 trials

Showing 20 of 49 results

Testing effectiveness (Phase 2)UnknownNCT01494415
What this trial is testing

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous Cell
First People's Hospital of Hangzhou 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT06380348
What this trial is testing

JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations

Who this might be right for
Local Advanced or Metastatic NSCLC
Shanghai JMT-Bio Inc. 398
Testing effectiveness (Phase 2)Study completedNCT00887783
What this trial is testing

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Odense University Hospital 117
Large-scale testing (Phase 3)UnknownNCT05111197
What this trial is testing

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Who this might be right for
Locally Advanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Institut Cancerologie de l'Ouest 112
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Post-approval studies (Phase 4)UnknownNCT01211002
What this trial is testing

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Simcere Pharmaceutical Co., Ltd 170
Large-scale testing (Phase 3)Study completedNCT00478049
What this trial is testing

Iressa as Second Line Therapy in Advanced NSCLC-Asia

Who this might be right for
NSCLC
AstraZeneca 163
Testing effectiveness (Phase 2)Study completedNCT00888511
What this trial is testing

Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Olfred Hansen 15
Testing effectiveness (Phase 2)Looking for participantsNCT07073365
What this trial is testing

Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)

Who this might be right for
Non-Small Cell Lung CancerEpidermal Growth Factor Receptor
Pusan National University Hospital 70
Early research (Phase 1)Not Yet RecruitingNCT07675876
What this trial is testing

Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerLung Adenocarcinoma
Carcinex Inc 10
Large-scale testing (Phase 3)Ended earlyNCT02766140
What this trial is testing

SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableUnknownNCT03046316
What this trial is testing

Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy

Who this might be right for
Lung Neoplasms
Guangdong Association of Clinical Trials 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888402
What this trial is testing

Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC

Who this might be right for
Local Advanced Non-small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Early research (Phase 1)UnknownNCT00846443
What this trial is testing

Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer

Who this might be right for
Local Advanced Non-Small Cell Lung Cancer
Fudan University 12
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00115518
What this trial is testing

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Heidelberg University 30
Testing effectiveness (Phase 2)Ended earlyNCT03661567
What this trial is testing

Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 52
Not applicableStudy completedNCT05205226
What this trial is testing

Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 636
Testing effectiveness (Phase 2)Study completedNCT00915005
What this trial is testing

Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence

Who this might be right for
Non-Small-Cell Lung Carcinoma
M.D. Anderson Cancer Center 275
Testing effectiveness (Phase 2)Looking for participantsNCT07415005
What this trial is testing

Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation